Vimarsana
Biggest News Aggregation in the World

Page 24 - Cell Press News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Press. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Press Today - Breaking & Trending Today

DNA discovery may assist in fight against agg - Vimarsana News

DNA discovery may assist in fight against agg

In a significant development in the fight against fatal cancers, University of Otago researchers have pinpointed a key feature that leads to the aggressive spread of colon cancer. Led by Associate Professor Aniruddha Chatterjee and Drs Euan Rodger and Rachel Purcell, researchers discovered abnormalities in the DNA instruction code that lead to the aggressive spread of colorectal (bowel) cancer – Aotearoa’s second highest cause of cancer death.

Modern humans interbred with Denisovans twice in history - Vimarsana News

Modern humans interbred with Denisovans twice in history

Public Release: 15-Mar-2018 Cell Press IMAGE: This graphical abstract shows two waves of Denisovan ancestry have shaped present-day humans. Credit: Browning et al./Cell Modern humans co-existed and interbred not only with Neanderthals, but also with another species of archaic humans, the mysterious Denisovans. While developing a new genome-analysis method for comparing whole genomes between modern…

Mushrooms may hold the secret to solving the climate crisis - Vimarsana News

Mushrooms may hold the secret to solving the climate crisis

A group of fungi store more than 13 million tons of carbon dioxide annually.

Pumping the brakes on autoimmune disease - Vimarsana News

Pumping the brakes on autoimmune disease

A new study from researchers at Sanford Burnham Prebys and Eli Lilly and Company describes the science behind an autoimmune disease treatment in a Phase 2 clinical trial.

Study provides a treasure trove of information on molecular biology of the immune system - Vimarsana News

Study provides a treasure trove of information on molecular biology of the immune system

Researchers at Sanford Burnham Prebys, collaborating with scientists from Eli Lilly and Company, have revealed the structure and function of a drug called LY3361237, which can reduce the harmful activity of the immune system to help treat autoimmune diseases.